Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 14, 2017; 23(30): 5519-5529
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5519
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5519
Figure 3 Immunohistochemical analyses of interleukin-26 receptor expression in normal and active/inactive inflammatory bowel disease mucosa.
A: Dual-colored immunofluorescence was used to localize α-SMA (red fluorescence) and IL-26 receptor, IL-10R2 and IL-20R1 (green fluorescence). Dual positive immunostaining can be seen as yellow fluorescence in the merged images. Pictures are shown from one of four independent samples with similar results. Magnification × 200; B: The expression of IL-26 receptor in human colonic SEMFs isolated from four different surgical samples. The expression of IL-26 receptor was evaluated by RT-PCR. SMA: Smooth muscle actin; IL: Interleukin; SEMFs: Subepithelial myofibroblasts.
- Citation: Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A. Expression of Interleukin-26 is upregulated in inflammatory bowel disease. World J Gastroenterol 2017; 23(30): 5519-5529
- URL: https://www.wjgnet.com/1007-9327/full/v23/i30/5519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i30.5519